The impact of comorbidity burden on the cardiovascular risk in the Peripheral Arteriopathy and Cardiovascular Events study

QJM: An International Journal of Medicine

Volumn 101, Issue 7, 2008, Pages 575-582

  Brevetti, G ^a,b   Giugliano, G ^a   Oliva, G ^a   Lanero, S ^a   De maio, J J ^a   Chiariello, M ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; CALCULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RATING SCALE; RISK ASSESSMENT; SCORING SYSTEM; STROKE; SURVIVAL RATE;

EID: 46249122919     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcn056     Document Type: Article

References (34)

1. van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA. Multimorbidity in general practice: Prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 1998; 51:367-75.
2. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40:373-83.
3. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. The impact of co-morbidity on life expectancy among men with localized prostate cancer. JAMA 1996; 156:127-32.
4. Dodds TA, Martin DP, Stolov WC, Deyo RA. A validation of the functional independent measurement and its performance among rehabilitation inpatients: Arch Phys Med Rehabil 1993; 74:531-36.
5. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45:613-19.
6. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 1998; 18:185-92.
7. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20:384-92.
8. Stoffers HE, Rinkens PE, Kester AD, Kaiser V, Knottnerus JA. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol 1996; 25:282-90.
9. Kugler C, Rudofsky G. The role of comorbidity burden for patients with symptomatic peripheral arterial disease (PAD). A quantitative approach. Int Angiol 2003; 22:290-301.
10. Heidrich H. Frequency of non-vascular accompanying diseases in patients with peripheral arterial disease. Vasa 2004; 33:155-8.
11. McDermott MM, Guralnik JM, Ferrucci L, Criqui MH, Greenland P, Tian L, et al. Functional decline in lower-extremity peripheral arterial disease: Associations with comorbidity, gender, and race. J Vasc Surg 2005; 42: 1131-7.
12. Parmelee PA, Thuras PD, Katz IR, Lawton MP. Validation of the Cumulative illness Rating Scale in a geriatric residential population. J Am Geriatr Soc 1995; 43:130-7.
13. Conwell Y, Forbes NT, Cox C, Caine ED. Validation of a measure of physical illness burden at autopsy: The Cumulative Illness Rating Scale. J Am Geriatr Soc 1993; 41:38-41.
14. Nagaratnam N, Gayagay G Jr. Validation of the Cumulative Illness Rating Scale (CIRS) in hospitalized nonagenarians. Arch Gerontol Geriatr 2007; 44:29-36.
15. Boulos DL, Groome PA, Brundage MD, Siemens DR, Mackillop WJ, Heaton JP, et al. Predictive validity of five comorbidity indices in prostate carcinoma patients treated with curative intent. Cancer 2006; 106:1804-14.
16. Giaquinto S, Palma E, Maiolo I, Piro MT, Roncacci S, Sciarra A, et al Importance and evaluation of comorbidity in rehabilitation. Disabil Rehabil 2001; 23:296-9.
17. Bo M, Cacello E, Chiggia F, Corsinovi L, Bosco F. Predictive factors of clinical outcome in older surgical patients. Arch Gerontol Geriatr 2007; 44:215-24.
18. Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer 2000; 36:453-71.
19. Brevetti G, Oliva G, Silvestro A, Scopacasa F, Chiariello M. Peripheral Arteriopathy and Cardiovascular Events (PACE) Study Group. Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy. Atherosclerosis 2004; 175:131-8.
20. Brevetti G, Schiano V, Verdoliva S, Silvestro A, Sirico G, De Maio J, et al. Peripheral arterial disease and cardiovascular risk in Italy. Results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study. J Cardiovasc Med 2006; 7:608-13.
21. Fronek A, Coel M, Berstein EF. Quantitative ultrasonographic studies of lower extremity flow velocities in health and disease. Circulation 1976; 53:957-60.
22. Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care 2006; 29: 725-31.
23. Cox DR. Regression and life tables. J R Stat Soc 1972; 34 187-220.
24. Newman AB, Shemanski L, Manolio TA, Cushmam M, Mittelmark M, Polak JF, et al. Ankle-arm index as a predictor of cardiovascular disease and-mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 1999; 19 538-45.
25. Aronow WS. Clinical causes of death of 2372 older persons in a nursing home during 15-year follow-up. J Am Med Dir Assoc 2000; 1 95-6.
26. Kannel WB. The demographics of claudication and the aging of the American population. Vasc Med 1996; 1:60-4.
27. Kannel WB, Skinner JJ Jr, Schwartz MJ, Shurtleff D. Intermittent claudication. Incidence in the Framingham Study. Circulation 1970; 41:875-83.
28. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20:537-44.
29. Park YW, Zhu S, Palaniappan L, Heshka S,, Carnethon MR, Heymsfield SB. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163 427-36.
30. Blumenthal JA, Babyak MA, Moore KA, Craighead WE, Herman S, Khatri P, et al. Effects of exercise training on older patients with major depression. Arch Intern Med 1999; 159:2349-56.
31. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: The Bruneck study. Diabetes Care 2007; 30:318-24.
32. Onat A, Ceyhan K, Basar Q, Erer B, Toprak S, Sansoy V. Metabolic syndrome: Major impact on coronary risk in a population with low cholesterol levels-a prospective and cross-sectional evaluation. Atherosclerosis 2002; 165: 285-92.
33. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996; 93:1976-80.
34. McLafferty RB, Dunnington GL, Mattos MA, Markwell SJ, Ramsey DE, Henretta JP, et al. Factors affecting the diagnosis of peripheral vascular disease before vascular surgery referral. J Vasc Surg 2000; 31:870-9.